< Back to All Resources
SAMHSA, with oversight by a steering committee of 13 other federal agencies and offices, has undertaken to develop a critically needed document: a clinical guide (hereafter referred to as the guide) that will inform health providers’ decisions regarding the evaluation, care, and treatment of pregnant and parenting women with opioid use disorder and their opioid-exposed infants.
External Link
https://www.regulations.gov/document?D=SAMHSA-2016-0002-0001
Related Topics
- Behavioral Health
- Children 0-5
- Medications for Addiction Treatment (MAT)
- Medical Care
- Clinical Tools